Press release article from our research archive:
|
|
AVAX Provides Regulatory Update.
- Article from:
-
PR Newswire
- Article date:
-
April 23, 2001
|
Copyright informationCOPYRIGHT 2001 PR Newswire Association, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
KANSAS CITY, Mo., April 23 /PRNewswire Interactive News Release/ --
AVAX Technologies, Inc. (Nasdaq: AVXT) announced today that it has received written notifications from the U.S. Food and Drug Administration (FDA) confirming the previously-reported clinical hold of AVAX's M-Vax and O-Vax autologous cancer vaccine clinical trials. The written notifications contain numerous FDA comments, questions and requests for additional information concerning the M-Vax and O-Vax products and clinical trials, and goes beyond the scope of prior oral communications from the FDA. The FDA request for additional information, while including issues related to the sterility of tumor cells ...
Related newspaper, magazine, and journal articles:
|
AVAX Technologies Responds to Food and Drug Administration's Clinical Hold...
PR Newswire;
August 16, 2001 ;
643 words
......Company, and the Company's manufacturing...release from the clinical hold. In addition to...response to the clinical hold, we have continued...days to review the Company's submission. Further...release from the clinical hold. AVAX Technologies is a biotechnology ...
|
|
AVAX Technologies Receives Additional Correspondence From the Food and...
PR Newswire;
September 21, 2001 ;
615 words
......today announced that the Company has received additional...from the FDA related to its clinical hold for the clinical trials of M-Vax and O-Vax...begin planning our worldwide clinical and registration strategies...another 30 days to review the Company's new response. ...
|
|
Government Extends Deadline by Which VaxGen is Required to Resolve...
PR Newswire;
November 16, 2006 ;
540 words
......by which the company is required to resolve a clinical hold imposed by the...had imposed a clinical hold on the company's forthcoming...informed the company that it had until...2006 to cure the clinical hold or the government...
|
|
FDA Maintains Clinical Hold on VaxGen's Anthrax Vaccine Trial.
PR Newswire;
December 18, 2006 ;
555 words
......has informed the company that it is maintaining its clinical hold on the company's second Phase...to engage the company in additional...However, the clinical hold will remain in...biopharmaceutical company engaged in the...to resolve the clinical hold ...
|
|
ViaCell Announces Clinical Hold Formalizing Suspension of Enrollment in...
PR Newswire;
September 21, 2005 ;
622 words
...-- Clinical Hold Not in Response...has placed a clinical hold on the Company's Phase I clinical...cancers. The clinical hold is not in response...the study. The clinical hold formalizes an...biotechnology company focused on enabling...resumption of ...
|
|
FDA Maintains Clinical Hold on Alteon's ED Study of Alagebrium.
PR Newswire;
September 30, 2005 ;
700+ words
......maintaining the clinical hold previously placed on the Company's Phase 2a...placed on clinical hold further enrollment...study, the Company's Phase 2a...which the Company submitted...maintain the clinical hold pending further...
|
|
FDA Lifts Clinical Hold on Genta's Tesetaxel, a Leading Oral Taxane.
PR Newswire;
June 23, 2008 ;
700+ words
......announced that the Company has received notification...response to the Company's submission of...placed the drug on clinical hold . We believe tesetaxel...biopharmaceutical company with a diversified...recently entered clinical trials as a potential...accelerated bone loss. The ...
|
|
Triangle Pharmaceuticals Announces Clinical Hold on Study FTC-302.
PR Newswire;
April 7, 2000 ;
553 words
......FDA), the FDA has issued a clinical hold on study FTC-302 which is...considered in issuing the clinical hold, study FTC-302 may not provide...second half of 2001, and the Company will continue discussions...specialty pharmaceutical company engaged in the development...including the ...
|
|
Valopicitabine Development Program Placed on Clinical Hold in the United...
PR Newswire;
July 13, 2007 ;
700+ words
......treatment of hepatitis C has been placed on clinical hold in the United States based on the overall risk...Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery, development and commercialization...and the potential impact of the valopicitabine clinical hold on ...
|
|
Avant Responds To FDA's Clinical Hold Letter.
PR Newswire;
August 27, 2001 ;
700+ words
......announced that the Company has responded...related to the clinical hold of AVANT's TP10...announced, the Company temporarily suspended...pediatric program on clinical hold, pending their...to review the Company's submission...complete lift of the clinical hold. ...
|
|
Biotechnology Firm to Merge with Drug Delivery Company in New Jersey.
Knight Ridder/Tribune Business News;
November 1, 2002 ;
438 words
......with privately held Lavipharm Corp., a drug delivery company in New Jersey. Lavipharm executives will manage the merged company, which will be publicly traded and called Lavipharm...president and chief executive of Zonagen, said the company will pay about $20 million in cash for a 56 percent...Lavipharm ...
|
|
Vion Pharmaceuticals Announces FDA Lift of Clinical Hold on Phase III...
PR Newswire;
January 8, 2008 ;
700+ words
...Company to Hold Conference Call...Administration (FDA) had lifted the clinical hold on the Phase III trial...interim analysis. The Company's medical consultants...the American Society of Clinical Oncology (ASCO(R)) in...with other therapies. The Company has announced previously...
|
|
NexMed Announces the FDA'S Lifting of Partial Clinical Hold.
PR Newswire;
February 27, 2003 ;
437 words
......Agency ) has lifted the partial clinical hold on the Alprox-TD cream for...previously announced, the Company met with the FDA on January...due to the results of the Company's 26-week Dermal Carcinogenicity...completed in December 2002. The Company is currently reviewing and...
|
|
FDA Lifts Clinical Hold on DOV Pharmaceutical's Ocinaplon Subject to...
PR Newswire;
June 28, 2004 ;
700+ words
......FDA) has agreed to lift the clinical hold on ocinaplon, the Company's novel anxiolytic, subject...protocol, and requested that the clinical hold be lifted. The FDA will allow...including ones proposed by the Company, to more closely monitor potential...
|
|
FDA Places a Partial Clinical Hold on Cell Genesys' GVAX Phase 3 Program...
Health & Beauty Close-Up;
September 16, 2008 ;
560 words
......2008-FDA Places a Partial Clinical Hold on Cell Genesys' GVAX Phase...expected, placed a partial clinical hold on the GVAX Phase 3 program...cancer as a result of the company's announcement on August...product. In a release, the company noted: The FDA has confirmed...VITAL-1 trial, ...
|
See all results.
Or, try our
Advanced Search.
|